Jefferies Group’s Achillion Pharmaceuticals ACHN Stock Holding History

Jefferies Group’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-285,100	Closed	-$1.72M	–	2946
2019 Q4	$1.72M	Buy	+285,100	New	+$1.65M	0.01%	1135
2018 Q2	–	Sell	-12,300	Closed	-$46K	–	2846
2018 Q1	$46K	Buy	+12,300	New	+$40.3K	﹤0.01%	2124

Jefferies Group's ACHN Position: Q1 2020 in Review

Jefferies Group sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 577,179 shares — an estimated $3.48M sold.

Jefferies Group first reported a position in ACHN in Q1 2014 and held it in 12 quarters. The position peaked at $3.48M in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

Jefferies Group reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Jefferies Group sold 577,179 Achillion Pharmaceuticals shares in Q1 2020, an estimated $3.48M.
Jefferies Group first reported a position in Achillion Pharmaceuticals in Q1 2014 and held it in 12 quarters.
Jefferies Group's Achillion Pharmaceuticals position peaked at $3.48M in Q4 2019.
0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Jefferies Group's 13F filing for Q1 2020, filed 15 May 2020.